Care Access and Eli Lilly and Company Partner to Increase Diversity Within Oncology Clinical Trials

BOSTON–(BUSINESS WIRE)–Sep 28, 2021– Care Access , the world’s leading decentralized research organization (DRO), today announced its expanded partnership with global biopharma leader Eli Lilly and Company (Lilly) to broaden patient access to clinical trials and increase representation of minority group members, including African American, Hispanic, and LatinX populations.

Read the source article at businesswire.com
2021-09-28 01:00:00